Clinical Characteristics and Outcomes of Fungal Keratitis in the United Kingdom 2011–2020: A 10-Year Study

Fungal keratitis (FK) is a serious ocular infection that often poses significant diagnostic and therapeutic dilemmas. This study aimed to examine the causes, clinical characteristics, outcomes, and prognostic factors of FK in the UK. All culture-positive and culture-negative presumed FK (with complete data) that presented to Queen’s Medical Centre, Nottingham, and the Queen Victoria Hospital, East Grinstead, between 2011 and 2020 were included. We included 117 patients (n = 117 eyes) with FK in this study. The mean age was 59.0 ± 19.6 years (range, 4–92 years) and 51.3% of patients were female. Fifty-three fungal isolates were identified from 52 (44.4%) culture-positive cases, with Candida spp. (33, 62.3%), Fusarium spp. (9, 17.0%), and Aspergillus spp. (5, 9.4%) being the most common organisms. Ocular surface disease (60, 51.3%), prior corneal surgery (44, 37.6%), and systemic immunosuppression (42, 35.9%) were the three most common risk factors. Hospitalisation for intensive treatment was required for 95 (81.2%) patients, with a duration of 18.9 ± 16.3 days. Sixty-six (56.4%) patients required additional surgical interventions for eradicating the infection. Emergency therapeutic/tectonic keratoplasty was performed in 29 (24.8%) cases, though 13 (44.8%) of them failed at final follow-up. The final corrected-distance-visual-acuity (CDVA) was 1.67 ± 1.08 logMAR. Multivariable logistic regression analyses demonstrated increased age, large infiltrate size (>3 mm), and poor presenting CDVA (<1.0 logMAR) as significant negative predictive factors for poor visual outcome (CDVA of <1.0 logMAR) and poor corneal healing (>60 days of healing time or occurrence of corneal perforation requiring emergency keratoplasty; all p < 0.05). In conclusion, FK represents a difficult-to-treat ocular infection that often results in poor visual outcomes, with a high need for surgical interventions. Innovative treatment strategies are urgently required to tackle this unmet need.

[1]  D. Ting,et al.  Diagnostic armamentarium of infectious keratitis: A comprehensive review , 2021, The ocular surface.

[2]  D. Ting,et al.  Surgical management of infectious keratitis. , 2021, The ocular surface.

[3]  Savitri Sharma,et al.  Masked comparison of trypan blue stain and potassium hydroxide with calcofluor white stain in the microscopic examination of corneal scrapings for the diagnosis of microbial keratitis , 2021, Indian journal of ophthalmology.

[4]  D. Ting,et al.  Risk Factors, Clinical Outcomes, and Prognostic Factors of Bacterial Keratitis: The Nottingham Infectious Keratitis Study , 2021, Frontiers in Medicine.

[5]  Travis K. Redd,et al.  Differentiation of Active Corneal Infections From Healed Scars Using Deep Learning. , 2021, Ophthalmology.

[6]  J. Mehta,et al.  Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes , 2021, Frontiers in Medicine.

[7]  A. Shih,et al.  Using Slit-Lamp Images for Deep Learning-Based Identification of Bacterial and Fungal Keratitis: Model Development and Validation with Different Convolutional Neural Networks , 2021, Diagnostics.

[8]  D. Ting,et al.  Artificial Intelligence in Cornea, Refractive Surgery, and Cataract: Basic Principles, Clinical Applications, and Future Directions. , 2021, Asia-Pacific journal of ophthalmology.

[9]  H. Dua,et al.  Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis , 2021, Scientific Reports.

[10]  C. Petsoglou,et al.  Twenty years since the Herpetic Eye Disease Study: Lessons, developments and applications to clinical practice , 2021, Clinical & experimental optometry.

[11]  S. Watson,et al.  Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia , 2021, Asia-Pacific journal of ophthalmology.

[12]  H. Dua,et al.  Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance , 2021, Eye.

[13]  M. Burton,et al.  The global incidence and diagnosis of fungal keratitis. , 2020, The Lancet. Infectious diseases.

[14]  S. Kaye,et al.  16S Ribosomal RNA PCR Versus Conventional Diagnostic Culture in the Investigation of Suspected Bacterial Keratitis , 2020, Translational vision science & technology.

[15]  C. R. Stensvold,et al.  Detection and Identification of Acanthamoeba and Other Nonviral Causes of Infectious Keratitis in Corneal Scrapings by Real-Time PCR and Next-Generation Sequencing-Based 16S-18S Gene Analysis , 2020, Journal of Clinical Microbiology.

[16]  N. Sharma,et al.  Infectious Keratitis Following Lamellar Keratoplasty. , 2020, Survey of ophthalmology.

[17]  H. Dua,et al.  Seasonal patterns of incidence, demographic factors and microbiological profiles of infectious keratitis: the Nottingham Infectious Keratitis Study , 2020, Eye.

[18]  F. Falcão-Reis,et al.  A 10-Year Retrospective Clinical Analysis of Fungal Keratitis in a Portuguese Tertiary Centre , 2020, Clinical Ophthalmology.

[19]  Mohit Sharma,et al.  Clinical characteristics, predisposing factors, and treatment outcome of Curvularia keratitis , 2020, Indian journal of ophthalmology.

[20]  H. Dua,et al.  Antimicrobial peptides in human corneal tissue of patients with fungal keratitis , 2020, British Journal of Ophthalmology.

[21]  H. Dua,et al.  Re: Prajna et al.: Cross-Linking-Assisted Infection Reduction (CLAIR): A randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis (Ophthalmology. 2020;127:159-166). , 2020, Ophthalmology (Rochester, Minn.).

[22]  L. Worden,et al.  Evaluation of Metagenomic Deep Sequencing as a Diagnostic Test for Infectious Keratitis. , 2020, Ophthalmology.

[23]  H. Dua,et al.  12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study , 2020, British Journal of Ophthalmology.

[24]  Marcus Ang,et al.  Artificial intelligence for anterior segment diseases: Emerging applications in ophthalmology , 2020, British Journal of Ophthalmology.

[25]  H. Dua,et al.  Strategies in Translating the Therapeutic Potentials of Host Defense Peptides , 2020, Frontiers in Immunology.

[26]  D. Ting,et al.  Arthrographis kalrae Keratitis Complicated by Endophthalmitis: A Case Report With Literature Review. , 2020, Eye & contact lens.

[27]  Monica Lahra,et al.  Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[28]  R. Agrawal,et al.  Rational substitution of ε-lysine for α-lysine enhances the cell and membrane selectivity of pore-forming melittin. , 2020, Journal of medicinal chemistry.

[29]  H. Dua,et al.  Interface Haze After Descemet Stripping Automated Endothelial Keratoplasty. , 2019, JAMA ophthalmology.

[30]  J. Rose-Nussbaumer,et al.  Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis. , 2019, Ophthalmology.

[31]  H. Dua,et al.  Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis. , 2019, The ocular surface.

[32]  D. Ting,et al.  Microbial keratitis complicated by acute hydrops following corneal collagen cross‐linking for keratoconus , 2019, Clinical & experimental optometry.

[33]  D. Tole,et al.  An 11-year analysis of microbial keratitis in the South West of England using brain–heart infusion broth , 2019, Eye.

[34]  Lixia Lin,et al.  Nine-year analysis of isolated pathogens and antibiotic susceptibilities of microbial keratitis from a large referral eye center in southern China , 2019, Infection and drug resistance.

[35]  Saurabh Ghosh,et al.  Polymicrobial Keratitis With Cryptococcus curvatus, Candida parapsilosis, and Stenotrophomonas maltophilia After Penetrating Keratoplasty: A Rare Case Report With Literature Review , 2019, Eye & contact lens.

[36]  A. Abdel-Hadi,et al.  Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of Fusarium and Aspergillus Isolates from Corneal Scrapings , 2019, BioMed research international.

[37]  Darren Shu Jeng Ting,et al.  Herpes zoster ophthalmicus , 2019, British Medical Journal.

[38]  J. Borysowski,et al.  Perspectives of Phage Therapy in Non-bacterial Infections , 2019, Front. Microbiol..

[39]  F. Stapleton,et al.  Queensland Microbial Keratitis Database: 2005–2015 , 2019, British Journal of Ophthalmology.

[40]  Monica Lahra,et al.  Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report , 2018, Clinical & experimental ophthalmology.

[41]  Cecilia S Lee,et al.  Clinical metagenomics for infectious corneal ulcers: Rags to riches? , 2019, The ocular surface.

[42]  J. Mehta,et al.  The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia. , 2018, American journal of ophthalmology.

[43]  M. Burton,et al.  In Vivo Confocal Microscopy Cellular Features of Host and Organism in Bacterial, Fungal, and Acanthamoeba Keratitis , 2018, American journal of ophthalmology.

[44]  Lixin Xie,et al.  Clinical analysis of fungal keratitis in patients with and without diabetes , 2018, PloS one.

[45]  Saurabh Ghosh,et al.  A 10-year analysis of microbiological profiles of microbial keratitis: the North East England Study , 2018, Eye.

[46]  J. Dart,et al.  Acanthamoeba keratitis in 194 patients: risk factors for bad outcomes and severe inflammatory complications , 2017, British Journal of Ophthalmology.

[47]  M. Srinivasan,et al.  Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II , 2017, JAMA ophthalmology.

[48]  C. Fullwood,et al.  Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital , 2017, Eye.

[49]  S. Tuft,et al.  Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study , 2016, American journal of ophthalmology.

[50]  Savitri Sharma,et al.  Comparison Between Polymicrobial and Fungal Keratitis: Clinical Features, Risk Factors, and Outcome. , 2015, American journal of ophthalmology.

[51]  Liya Wang,et al.  Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method , 2015, Current eye research.

[52]  M. Srinivasan,et al.  Trends in bacterial and fungal keratitis in South India, 2002–2012 , 2014, British Journal of Ophthalmology.

[53]  M. Srinivasan,et al.  Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. , 2014, American journal of ophthalmology.

[54]  M. Srinivasan,et al.  Differences in clinical outcomes in keratitis due to fungus and bacteria. , 2013, JAMA ophthalmology.

[55]  M. Srinivasan,et al.  Seasonal Trends of Microbial Keratitis in South India , 2012, Cornea.

[56]  M. Srinivasan,et al.  Predictors of outcome in fungal keratitis , 2012, Eye.

[57]  M. Srinivasan,et al.  Organism, Minimum Inhibitory Concentration, and Outcome in a Fungal Corneal Ulcer Clinical Trial , 2012, Cornea.

[58]  I. Kansakar,et al.  Pattern of fungal isolates in cases of corneal ulcer in the western periphery of Nepal. , 2011, Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH.

[59]  Emily W. Gower,et al.  Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study. , 2011, Ophthalmology.

[60]  M. Bach,et al.  Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT) , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[61]  S. Tuft,et al.  Fungal Keratitis in London: Microbiological and Clinical Evaluation , 2007, Cornea.